UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Considerations on nonclinical approaches to modeling risk factors of suicidal ideation and behavior

Regulatory toxicology and pharmacology, 2017-10, Vol.89, p.288-301

2017

Volltextzugriff (PDF)

Cognition, prior aggression, and psychopathic traits in relation to impaired multimodal emotion recognition in psychotic spectrum disorders

Frontiers in psychiatry, 2023, Vol.14, p.1111896-1111896

2023

Volltextzugriff (PDF)

Design, Synthesis, and Pharmacological Characterization of (+)-2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY354740): A Potent, Selective, and Orally Active Group 2 Metabotropic Glutamate Receptor Agonist Possessing Anticonvulsant and Anxiolytic Properties

Journal of medicinal chemistry, 1997-02, Vol.40 (4), p.528-537

1997

Volltextzugriff (PDF)

Ant-plant sociometry in the Azteca-Cecropia mutualism

Scientific reports, 2018-12, Vol.8 (1), p.17968-15, Article 17968

2018

Volltextzugriff (PDF)

Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors

The Journal of pharmacology and experimental therapeutics, 1998-02, Vol.284 (2), p.651

1998

Volltextzugriff (PDF)

LY354740: a metabotropic glutamate receptor agonist which ameliorates symptoms of nicotine withdrawal in rats

Neuropharmacology, 1997-11, Vol.36 (11), p.1511-1516

1997

Volltextzugriff (PDF)

ADAR2 A-->I editing: site selectivity and editing efficiency are separate events

Nucleic acids research, 2003-08, Vol.31 (16), p.4874-4881

2003

Volltextzugriff (PDF)

2-Substituted (2SR)-2-Amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as Potent and Selective Antagonists of Group II Metabotropic Glutamate Receptors. 2. Effects of Aromatic Substitution, Pharmacological Characterization, and Bioavailability

Journal of medicinal chemistry, 1998-01, Vol.41 (3), p.358-378

1998

Volltextzugriff (PDF)

Moxonidine, a selective imidazoline-1 receptor agonist, suppresses the effects of ethanol withdrawal on the acoustic startle response in rats

Biological psychiatry (1969), 2000-05, Vol.47 (10), p.874-879

2000

Volltextzugriff (PDF)

RNA editing and alternative splicing: the importance of co-transcriptional coordination

EMBO reports, 2006-03, Vol.7 (3), p.303-307

2006

Volltextzugriff (PDF)

Psychotically driven aggression is associated with greater mentalizing challenges in psychotic spectrum disorders

BMC psychiatry, 2020-09, Vol.20 (1), p.470-470, Article 470

2020

Volltextzugriff (PDF)

Time to identify CAM-users during oncology treatment: The results of a regional survey in Sweden

ANNALS OF ONCOLOGY, 2023, Vol.34, p.S1237

2023

Volltextzugriff (PDF)

The Death of Idealism: Development and Anti-Politics in the Peace Corps

Kallman, Meghan Elizabeth

1, 2020

Volltextzugriff (PDF)

Use of CAM among cancer patients : Results of a regional survey in Sweden

BMC complementary medicine and therapies, 2023-02, Vol.23 (1), p.51, Article 51

2023

Volltextzugriff (PDF)

LY303870, a centrally active neurokinin-1 antagonist with a long duration of action

The Journal of pharmacology and experimental therapeutics, 1997-02, Vol.280 (2), p.774

1997

Volltextzugriff (PDF)

Preclinical Abuse Potential Assessment

Handbook of experimental pharmacology, 2015, Vol.229, p.115

Kallman, Mary Jeanne

2015

Volltextzugriff (PDF)

A comparison of patient ratings and staff ratings of disability using the World Health Organisation Disability Assessment Schedule in individuals with psychotic spectrum disorders who are forensic psychiatric inpatients

Criminal behaviour and mental health, 2024-08, Vol.34 (4), p.347-359

2024

Volltextzugriff (PDF)

The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine

The Journal of pharmacology and experimental therapeutics, 2000-08, Vol.294 (2), p.688

2000

Volltextzugriff (PDF)

Behavioral tolerance to the force differentiation effects of diazepam and midazolam in rats

Psychopharmacologia, 2000-03, Vol.148 (4), p.327-335

2000

Volltextzugriff (PDF)

Establishing performance characteristics for positive control article selection in drug self-administration studies

Journal of pharmacological and toxicological methods, 2019-05, Vol.97, p.13-23

2019

Volltextzugriff (PDF)

The CCK-B antagonist LY288513 blocks the effects of nicotine withdrawal on auditory startle

Neuroreport, 1996-04, Vol.7 (5), p.1050-1052

1996

Volltextzugriff (PDF)

In vitro analysis of the binding of ADAR2 to the pre-mRNA encoding the GluR-B R/G site

RNA (Cambridge), 2000-05, Vol.6 (5), p.687-697, Article S1355838200000200

2000

Volltextzugriff (PDF)

CN40 Time to identify CAM-users during oncology treatment: The results of a regional survey in Sweden

Annals of oncology, 2023-10, Vol.34, p.S1237-S1237

2023

Volltextzugriff (PDF)

Evaluation of the activity of a novel metabotropic glutamate receptor antagonist (±)-2-amino-2-(3- cis and trans-carboxycyclobutyl-3-(9-thioxanthyl)propionic acid) in the in vitro neonatal spinal cord and in an in vivo pain model

Neuroscience, 1999-12, Vol.95 (3), p.787-793

1999

Volltextzugriff (PDF)

Serotonin-1A antagonists attenuate the effects of nicotine withdrawal on the auditory startle response

Synapse (New York, N.Y.), 1997-10, Vol.27 (2), p.145-152

1997

Volltextzugriff (PDF)

1 – 25 von 560

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(492)
Mit Volltextzugriff
(478)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Considerations on nonclinical approaches to modeling risk factors of suicidal ideation and behavior

Cognition, prior aggression, and psychopathic traits in relation to impaired multimodal emotion recognition in psychotic spectrum disorders

Design, Synthesis, and Pharmacological Characterization of (+)-2-Aminobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY354740): A Potent, Selective, and Orally Active Group 2 Metabotropic Glutamate Receptor Agonist Possessing Anticonvulsant and Anxiolytic Properties

Ant-plant sociometry in the Azteca-Cecropia mutualism

Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors

LY354740: a metabotropic glutamate receptor agonist which ameliorates symptoms of nicotine withdrawal in rats

ADAR2 A-->I editing: site selectivity and editing efficiency are separate events

2-Substituted (2SR)-2-Amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as Potent and Selective Antagonists of Group II Metabotropic Glutamate Receptors. 2. Effects of Aromatic Substitution, Pharmacological Characterization, and Bioavailability

Moxonidine, a selective imidazoline-1 receptor agonist, suppresses the effects of ethanol withdrawal on the acoustic startle response in rats

RNA editing and alternative splicing: the importance of co-transcriptional coordination

Psychotically driven aggression is associated with greater mentalizing challenges in psychotic spectrum disorders

Time to identify CAM-users during oncology treatment: The results of a regional survey in Sweden

The Death of Idealism: Development and Anti-Politics in the Peace Corps

Use of CAM among cancer patients : Results of a regional survey in Sweden

LY303870, a centrally active neurokinin-1 antagonist with a long duration of action

Preclinical Abuse Potential Assessment

A comparison of patient ratings and staff ratings of disability using the World Health Organisation Disability Assessment Schedule in individuals with psychotic spectrum disorders who are forensic psychiatric inpatients

The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine

Behavioral tolerance to the force differentiation effects of diazepam and midazolam in rats

Establishing performance characteristics for positive control article selection in drug self-administration studies

The CCK-B antagonist LY288513 blocks the effects of nicotine withdrawal on auditory startle

In vitro analysis of the binding of ADAR2 to the pre-mRNA encoding the GluR-B R/G site

CN40 Time to identify CAM-users during oncology treatment: The results of a regional survey in Sweden

Evaluation of the activity of a novel metabotropic glutamate receptor antagonist (±)-2-amino-2-(3- cis and trans-carboxycyclobutyl-3-(9-thioxanthyl)propionic acid) in the in vitro neonatal spinal cord and in an in vivo pain model

Serotonin-1A antagonists attenuate the effects of nicotine withdrawal on the auditory startle response

Suchergebnisse filtern